Norges Bank’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$663M Buy
+2,032,680
New +$663M 0.08% 225
2025
Q1
Sell
-2,456,082
Closed -$578M 75
2024
Q4
$578M Buy
+2,456,082
New +$578M 0.08% 235
2024
Q3
Sell
-2,296,781
Closed -$558M 75
2024
Q2
$558M Buy
2,296,781
+4,127
+0.2% +$1M 0.08% 219
2024
Q1
$343M Buy
2,292,654
+252,856
+12% +$37.8M 0.05% 314
2023
Q4
$390M Buy
2,039,798
+846,232
+71% +$162M 0.07% 255
2023
Q3
$211M Buy
1,193,566
+490,212
+70% +$86.8M 0.04% 362
2023
Q2
$134M Sell
703,354
-818,058
-54% -$155M 0.03% 497
2023
Q1
$305M Buy
1,521,412
+508,566
+50% +$102M 0.07% 274
2022
Q4
$241M Sell
1,012,846
-205,338
-17% -$48.8M 0.06% 314
2022
Q3
$244M Sell
1,218,184
-66,593
-5% -$13.3M 0.06% 289
2022
Q2
$187M Sell
1,284,777
-10,310
-0.8% -$1.5M 0.05% 344
2022
Q1
$211M Buy
1,295,087
+25,896
+2% +$4.23M 0.05% 370
2021
Q4
$215M Buy
1,269,191
+274,303
+28% +$46.5M 0.04% 385
2021
Q3
$188M Buy
994,888
+100,136
+11% +$18.9M 0.04% 412
2021
Q2
$152M Sell
894,752
-67,552
-7% -$11.5M 0.03% 492
2021
Q1
$136M Sell
962,304
-76,684
-7% -$10.8M 0.03% 519
2020
Q4
$135M Sell
1,038,988
-1,361
-0.1% -$177K 0.03% 490
2020
Q3
$151M Buy
1,040,349
+138,030
+15% +$20.1M 0.04% 403
2020
Q2
$134M Sell
902,319
-85,446
-9% -$12.7M 0.04% 409
2020
Q1
$108M Sell
987,765
-15,448
-2% -$1.68M 0.04% 409
2019
Q4
$116M Sell
1,003,213
-121,009
-11% -$13.9M 0.03% 488
2019
Q3
$90.4M Sell
1,124,222
-14,780
-1% -$1.19M 0.03% 558
2019
Q2
$82.6M Sell
1,139,002
-7,867
-0.7% -$571K 0.03% 598
2019
Q1
$107M Sell
1,146,869
-145,507
-11% -$13.6M 0.03% 471
2018
Q4
$94.2M Buy
1,292,376
+159,445
+14% +$11.6M 0.04% 465
2018
Q3
$99.2M Buy
1,132,931
+314,695
+38% +$27.5M 0.03% 504
2018
Q2
$80.6M Buy
818,236
+14,273
+2% +$1.41M 0.03% 572
2018
Q1
$95.8M Buy
803,963
+61,702
+8% +$7.35M 0.03% 490
2017
Q4
$94.3M Buy
742,261
+187,242
+34% +$23.8M 0.03% 493
2017
Q3
$65.2M Sell
555,019
-189,396
-25% -$22.3M 0.02% 630
2017
Q2
$59.4M Buy
744,415
+100,000
+16% +$7.98M 0.02% 642
2017
Q1
$33M Sell
644,415
-20,248
-3% -$1.04M 0.01% 1011
2016
Q4
$24.9M Buy
664,663
+116,894
+21% +$4.38M 0.01% 1167
2016
Q3
$35.5M Buy
547,769
+87,008
+19% +$5.63M 0.02% 827
2016
Q2
$25.6M Buy
460,761
+31,380
+7% +$1.74M 0.01% 1047
2016
Q1
$27M Sell
429,381
-168,776
-28% -$10.6M 0.01% 972
2015
Q4
$56.3M Sell
598,157
-66,811
-10% -$6.29M 0.03% 559
2015
Q3
$53.4M Buy
664,968
+91,048
+16% +$7.32M 0.03% 552
2015
Q2
$68.8M Sell
573,920
-21,374
-4% -$2.56M 0.03% 512
2015
Q1
$62.2M Buy
595,294
+42,633
+8% +$4.45M 0.03% 559
2014
Q4
$53.6M Buy
552,661
+44,531
+9% +$4.32M 0.03% 610
2014
Q3
$39.7M Sell
508,130
-508,130
-50% -$39.7M 0.02% 732
2014
Q2
$64.2M Buy
1,016,260
+622,369
+158% +$39.3M 0.02% 845
2014
Q1
$26.4M Hold
393,891
0.01% 950
2013
Q4
$25.3M Buy
393,891
+15,873
+4% +$1.02M 0.01% 964
2013
Q3
$24.2M Buy
378,018
+61,614
+19% +$3.94M 0.01% 955
2013
Q2
$9.81M Buy
+316,404
New +$9.81M 0.01% 1483